The University of Southampton
×
Filter your search:
University of Southampton Institutional Repository

Fulvestrant for untreated hormone-receptor positive locally advanced metastatic breast cancer

Fulvestrant for untreated hormone-receptor positive locally advanced metastatic breast cancer
Fulvestrant for untreated hormone-receptor positive locally advanced metastatic breast cancer
The company’s submission (CS) reflects the scope of the appraisal issued by the National Institute for Health and Care Excellence (NICE). The submission assesses the clinical effectiveness and cost effectiveness of fulvestrant for untreated hormone-receptor positive locally advanced or metastatic breast cancer in comparison to aromatase inhibitors (AIs) (anastrozole and letrozole) or, when these are not tolerated or are contraindicated, tamoxifen.
Breast Cancer, fulvestrant
HTA - 16/54/04
National Institute for Health and Care Research
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
Kalita, Neelam
da42f168-a3cc-44c9-bafb-2801ff57914b
Harris, Petra
a8bd143b-3e2c-4929-9279-510a4c60bd09
Onyimadu, Oluchukwu
ff168bd7-1c4f-4756-a34a-7e6b930ae29b
Gaisford, Wendy C
f1f37a2e-d281-4577-8332-fef0f8b2c789
Picot, Joanna
324d6f20-a105-49fd-9fb0-88791be84ada
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
Kalita, Neelam
da42f168-a3cc-44c9-bafb-2801ff57914b
Harris, Petra
a8bd143b-3e2c-4929-9279-510a4c60bd09
Onyimadu, Oluchukwu
ff168bd7-1c4f-4756-a34a-7e6b930ae29b
Gaisford, Wendy C
f1f37a2e-d281-4577-8332-fef0f8b2c789
Picot, Joanna
324d6f20-a105-49fd-9fb0-88791be84ada

Cooper, Keith, Kalita, Neelam, Harris, Petra, Onyimadu, Oluchukwu, Gaisford, Wendy C and Picot, Joanna (2018) Fulvestrant for untreated hormone-receptor positive locally advanced metastatic breast cancer (Health Technology Assessment, HTA - 16/54/04) Southampton. National Institute for Health and Care Research 150pp.

Record type: Monograph (Project Report)

Abstract

The company’s submission (CS) reflects the scope of the appraisal issued by the National Institute for Health and Care Excellence (NICE). The submission assesses the clinical effectiveness and cost effectiveness of fulvestrant for untreated hormone-receptor positive locally advanced or metastatic breast cancer in comparison to aromatase inhibitors (AIs) (anastrozole and letrozole) or, when these are not tolerated or are contraindicated, tamoxifen.

Text
Fulvestrant for breast cancer - Evidence Review Groupe Report
Download (2MB)

More information

Published date: 2018
Related URLs:
Keywords: Breast Cancer, fulvestrant

Identifiers

Local EPrints ID: 417748
URI: http://eprints.soton.ac.uk/id/eprint/417748
PURE UUID: 3ffc8ed3-c9f0-426b-a954-179b27a46d31
ORCID for Keith Cooper: ORCID iD orcid.org/0000-0002-0318-7670
ORCID for Neelam Kalita: ORCID iD orcid.org/0000-0002-0973-0160
ORCID for Petra Harris: ORCID iD orcid.org/0000-0001-9257-3786
ORCID for Oluchukwu Onyimadu: ORCID iD orcid.org/0000-0002-1724-3485
ORCID for Wendy C Gaisford: ORCID iD orcid.org/0000-0002-2652-8757
ORCID for Joanna Picot: ORCID iD orcid.org/0000-0001-5987-996X

Catalogue record

Date deposited: 13 Feb 2018 17:30
Last modified: 10 Apr 2024 01:49

Export record

Contributors

Author: Keith Cooper ORCID iD
Author: Neelam Kalita ORCID iD
Author: Petra Harris ORCID iD
Author: Oluchukwu Onyimadu ORCID iD
Author: Wendy C Gaisford ORCID iD
Author: Joanna Picot ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information
Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×